Rapid Dose Therapeutics Corp. (CSE:DOSE)

Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Market Capitalization	20	22	21	9	26	17
Market Cap Growth	-21.06%	6.81%	121.17%	-64.76%	56.16%	-36.29%
Enterprise Value	26	25	23	11	28	18
Last Close Price	0.15	0.17	0.17	0.09	0.26	0.21
PS Ratio	7.29	10.56	20.20	12.98	15.10	22.43
PB Ratio	-3.05	-4.23	-6.53	-3.49	105.16	-15.54
P/TBV Ratio	-	-	-	-	105.16	-
EV/Sales Ratio	9.32	11.79	23.00	15.75	15.81	24.39
Debt / Equity Ratio	-0.87	-0.50	-0.78	-0.79	5.70	-2.01
Net Debt / Equity Ratio	-0.85	-0.50	-0.73	-0.78	5.56	-1.94
Net Debt / EBITDA Ratio	-2.14	-0.65	-0.83	-0.65	-0.37	-1.70
Net Debt / FCF Ratio	-6.49	-2.25	-1.00	-2.43	-0.46	-1.30
Asset Turnover	1.02	1.19	0.49	0.27	0.51	0.19
Inventory Turnover	5.88	4.25	2.79	1.67	1.26	0.43
Quick Ratio	0.05	0.05	0.13	0.04	0.09	0.08
Current Ratio	0.08	0.10	0.23	0.09	0.25	0.19
Return on Assets (ROA)	-70.49%	-148.14%	-93.37%	-83.34%	-77.93%	-25.16%
Return on Capital Employed (ROCE)	69.20%	80.10%	298.70%	134.20%	-698.60%	392.80%
Earnings Yield	-21.56%	-24.54%	-20.89%	-40.87%	-32.08%	-10.66%
FCF Yield	-4.30%	-5.23%	-11.13%	-9.27%	-11.49%	-9.64%
Buyback Yield / Dilution	-7.98%	-18.68%	-1.50%	-3.19%	-28.83%	-2.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.